ARTICLE | Clinical News
Curaxin quinacrine: Phase Ib started
November 8, 2010 8:00 AM UTC
Incuron LLC began an open-label, Russian Phase Ib trial of Curaxin quinacrine in up to 36 patients with liver metastases of solid tumors of epithelial origin or primary advanced hepatic carcinoma for ...